SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H.O.B. Oloyede, T.O. Bello, T.O. Ajiboye, M.O. Salawu, Antidiabetic and antidyslipidemic activities of aqueous leaf extract of Dioscoreophyllum cumminsii (Stapf) Diels in alloxan-induced diabetic rats, Journal of Ethnopharmacology, 2015, 166, 313

    CrossRef

  2. 2
    Ying Li, Xiu-xia Tian, Tiemin Liu, Rui-tao Wang, Association between whole blood viscosity and arterial stiffness in patients with type 2 diabetes mellitus, Endocrine, 2015, 49, 1, 148

    CrossRef

  3. 3
    O.B. Oloyede, T.O. Ajiboye, A.F. Abdussalam, A.O. Adeleye, Blighia sapida leaves halt elevated blood glucose, dyslipidemia and oxidative stress in alloxan-induced diabetic rats, Journal of Ethnopharmacology, 2014, 157, 309

    CrossRef

  4. 4
    Dalia El-Lebedy, Mona Kafoury, Dalia Abd-El Haleem, Alshaymaa Ibrahim, Eman Awadallah, Ingy Ashmawy, Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus, Journal of Diabetes & Metabolic Disorders, 2014, 13, 1

    CrossRef

  5. 5
    S.B. Patel, D. Santani, M.B. Shah, V.S. Patel, Anti-hyperglycemic and Anti-hyperlipidemic Effects of Bryonia Laciniosa Seed Extract and its Saponin Fraction in Streptozotocin-induced Diabetes in Rats, Journal of Young Pharmacists, 2012, 4, 3, 171

    CrossRef

  6. 6
    Chen-Dong Wang, Bao-Song Teng, Yan-Ming He, Jia-Sheng Wu, Deng Pan, Luan-Feng Pan, Dan Zhang, Zhao-Hua Fan, Hong-Jie Yang, Ping Zhou, Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice, British Journal of Nutrition, 2012, 108, 11, 2014

    CrossRef

  7. 7
    Seifollah Bahramikia, Razieh Yazdanparast, EUK-8 and EUK-134 reduce serum glucose and lipids and ameliorate streptozotocin-induced oxidative damage in the pancreas, liver, kidneys, and brain tissues of diabetic rats, Medicinal Chemistry Research, 2012, 21, 10, 3224

    CrossRef

  8. 8
    Gaurav Kaithwas, Dipak K. Majumdar, In vitro antioxidant and in vivo antidiabetic, antihyperlipidemic activity of linseed oil against streptozotocin-induced toxicity in albino rats, European Journal of Lipid Science and Technology, 2012, 114, 11
  9. 9
    Mi-Ja Kim, Hye Kyung Kim, Insulinotrophic and hypolipidemic effects of Ecklonia cava in streptozotocin–induced diabetic mice, Asian Pacific Journal of Tropical Medicine, 2012, 5, 5, 374

    CrossRef

  10. 10
    Shipra Gupta, Suman Bala Sharma, Usha Rani Singh, Surendra Kumar Bansal, Salutary Effect of Cassia auriculata L. Leaves on Hyperglycemia-Induced Atherosclerotic Environment in Streptozotocin Rats, Cardiovascular Toxicology, 2011, 11, 4, 308

    CrossRef

  11. 11
    Masanori Abe, Kazuyoshi Okada, Takashi Maruyama, Noriaki Maruyama, Koichi Matsumoto, Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis, Expert Opinion on Pharmacotherapy, 2010, 11, 2, 169

    CrossRef

  12. 12
    Hye-Won Jang, Moch. Saiful Bachri, Kyung-Ok Moon, Jong-Ok Park, Protective Effect of White-Skinned Sweet Potato (Ipomoea batatas L.) against Renal Damage in Streptozotocin-Induced Diabetic Rats, Journal of Life Science, 2010, 20, 2, 161

    CrossRef

  13. 13
    Moch. Saiful Bachri, Hye-Won Jang, Jong-Won Choi, Jong-Ok Park, Protective Effect of White-Skinned Sweet Potato (Ipomoea batatas L.) from Indonesia on Streptozotocin-Induced Oxidative Stress in Rats, Journal of Life Science, 2010, 20, 11, 1569

    CrossRef

  14. 14
    Shipra Gupta, Suman Bala Sharma, Surendra Kumar Bansal, Krishna Madhava Prabhu, Antihyperglycemic and hypolipidemic activity of aqueous extract of Cassia auriculata L. leaves in experimental diabetes, Journal of Ethnopharmacology, 2009, 123, 3, 499

    CrossRef

  15. 15
    P. K. M. Anu Geethan, P. Stanely Mainzen Prince, Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic wistar rats, Journal of Biochemical and Molecular Toxicology, 2008, 22, 4
  16. 16
    Michael E. Minshall, Alan K. Oglesby, Matthew E. Wintle, William J. Valentine, Stéphane Roze, Andrew J. Palmer, Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus, Value in Health, 2008, 11, 1
  17. 17
    Masanori Abe, Kazo Kaizu, Koichi Matsumoto, Evaluation of the Hemodialysis-induced Changes in Plasma Glucose and Insulin Concentrations in Diabetic Patients: Comparison Between the Hemodialysis and Non-hemodialysis Days, Therapeutic Apheresis and Dialysis, 2007, 11, 4
  18. 18
    M. Puig-Domingo, J. Reviriego, Las incretinas como nuevas dianas terapéuticas de la diabetes tipo 2, Revista Clínica Española, 2007, 207, 7, 352

    CrossRef

  19. You have free access to this content19
    L. Blonde, E. J. Klein, J. Han, B. Zhang, S. M. Mac, T. H. Poon, K. L. Taylor, M. E. Trautmann, D. D. Kim, D. M. Kendall, Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes, Diabetes, Obesity and Metabolism, 2006, 8, 4
  20. 20
    P. Stanely Mainzen Prince, N. K. Kannan, Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats, Journal of Pharmacy and Pharmacology, 2006, 58, 10
  21. 21
    Fumikado Fujiwara, Mototsugu Ishii, Haruhito Taneichi, Masanori Miura, Makiko Toshihiro, Noriko Takebe, Wataru Ishida, Yoshihito Kaneko, Akinobu Kato, Kazuyuki Suzuki, Jo Satoh, Low Incidence of Vascular Complications in Patients with Diabetes Mellitus Associated with Liver Cirrhosis as Compared with Type 2 Diabetes Mellitus, The Tohoku Journal of Experimental Medicine, 2005, 205, 4, 327

    CrossRef